Candidaemia with uncommon Candida species: Predisposing factors, outcome, antifungal susceptibility, and implications for management

Clinical Microbiology and Infection

Volumn 15, Issue 7, 2009, Pages 662-669

  Chen, Sharon C A ^a,e   Marriott, D ^b   Playford, E G ^c   Nguyen, Q ^b   Ellis, D ^d   Meyer, W ^a,e   Sorrell, T C ^a,e   Slavin, M ^f,ak,ap   McBride, J ^g   Coulter, C ^h,o   McCormack, J ⁱ   Walmsley, K ⁱ   Looke, D ^c   Johnson, B ^c   Nimmo, G ^c   Playford, G ^c   Drummond, D ^j   Forgan Smith, R ^j   Preston, E ^j   Allworth, A ^k   Faoagali, J ^l   Gerns, N ^l   Botes, J ^m   Cherian, S ^m   Robson, J ^m   Vohra, R ^m   Norton, R ⁿ   O'Kane, G ^o   Robb, D ^p   Gottlieb, T ^q   Chambers, I ^r   DeWit, D ^s   Carroll, M ^t   Dobson, P ^u   Ferguson, J ^u   Graves, S ^u,ar   Tierney, L ^u   Jozwiak, F ^v   Munro, R ^v   Tomasotos, V ^v   Pickles, R ^w   Holland, J ^x   Groenwad, F ^y   Hale, K ^z   Watson, M ^z   Vaz, R ^aa   Hardiman, R ^ab   Baleriola, C ^ab   Ryan, S ^ab   Pritchard, R ^ac   Weeks, K ^ac   Benn, R ^ad   Lawrence, R ^ae   Taylor, P ^ae   Lindstrom, S ^af   Harkness, J ^b   Palasanthrian, P ^ag   Grant, R ^ah   McPetrie, R ^ah   Johnson, R ^ai   Halliday, C ^e   Maszewska, K ^e   Dennis, N ^aj   Newton, P ^aj   Franklin, C ^ak   Morrisey, O ^ak   Spelman, D ^ak   Wesselingh, S ^ak   Speed, B ^al   Hellsten, J ^am   Mayall, B ^am   Russell, J ^am   Broughton, S ^an   Woolley, I ^an   Coloe, S ^ao   Sherman, A ^ap   Korman, T ^aq   Huysmans, M ^f   Gordon, D ^as   Rowlands, K ^at   Shaw, D ^at   Ritchie, B ^d   Handkle, R ^d   Beaman, M ^au   Chiam, A ^au   McCarthy, J ^au   Heath, C ^av   Altmann, S ^aw   Arthur, I ^aw   Speers, D ^aw   Cox, E ^ax   Cooley, L ^ay   McGregor, A ^ay   Currie, B ^az   Lum, G ^az   Fisher, D ^az   Collignon, P ^ba   Roberts, J ^ba   Watson, A ^ba   more..

^a UNIVERSITY OF SYDNEY   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

^f PETER MACCALLUM CANCER CENTRE   (Australia)

^g CAIRNS BASE HOSPITAL   (Australia)

^h Calboolture Hospital   (Australia)

ⁱ MATER ADULT HOSPITAL   (Australia)

^j Queensland Medical Laboratories   (Australia)

^k Queensland Government   (Australia)

^l ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^m SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

ⁿ TOWNSVILLE HOSPITAL   (Australia)

^o THE PRINCE CHARLES HOSPITAL   (Australia)

^p Albury Base Hospital   (Australia)

^q Department of Microbiology and Infectious Diseases   (Australia)

^r DOUGLASS HANLY MOIR PATHOLOGY   (Australia)

^s GOSFORD HOSPITAL   (Australia)

^t Griffith Hospital Base   (Australia)

^u JOHN HUNTER HOSPITAL   (Australia)

^v LIVERPOOL HOSPITAL   (Australia)

^w Manning Base Hospital   (Australia)

^x Mayne Health   (Australia)

^y Narrabri District Hospital   (Australia)

^z CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^aa Orange Base Hospital   (Australia)

^ab PRINCE OF WALES HOSPITAL   (Australia)

^ac ROYAL NORTH SHORE HOSPITAL   (Australia)

^ad ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^ae ST GEORGE HOSPITAL   (Australia)

^af St George Private Hospital   (Australia)

^ag SYDNEY CHILDREN'S HOSPITAL   (Australia)

^ah SYDNEY ADVENTIST HOSPITAL   (Australia)

^ai Wagga Wagga Base Hospital   (Australia)

^aj WOLLONGONG HOSPITAL   (Australia)

^ak ALFRED HOSPITAL   (Australia)

^al AUSTIN HEALTH   (Australia)

^am Monash University and Bendigo Health Care Group   (Australia)

^an FRANKSTON HOSPITAL   (Australia)

^ao MELBOURNE PATHOLOGY   (Australia)

^ap ROYAL MELBOURNE HOSPITAL   (Australia)

^aq MONASH MEDICAL CENTRE   (Australia)

^ar Department of Anatomical Pathology   (Australia)

^as FLINDERS MEDICAL CENTRE   (Australia)

^at ROYAL ADELAIDE HOSPITAL   (Australia)

^au FREMANTLE HOSPITAL   (Australia)

^av ROYAL PERTH HOSPITAL   (Australia)

^aw SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^ax Launceston General   (Australia)

^ay ROYAL HOBART HOSPITAL   (Australia)

^az ROYAL DARWIN HOSPITAL   (Australia)

^ba CANBERRA HOSPITAL   (Australia)

more..

Author keywords

Antifungal susceptibility; Candidaemia; Outcome; Risk factors; Uncommon Candida species

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GUILLIERMODII; CANDIDA LUSITANIAE; CANDIDEMIA; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDOCARDITIS; EYE INFECTION; FEMALE; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HEMATOLOGIC MALIGNANCY; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAOCULAR CANDIDIASIS; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; SEPSIS; SEX DIFFERENCE; STRAIN DIFFERENCE;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CLAVISPORA LUSITANIAE; HUMAN IMMUNODEFICIENCY VIRUS; PICHIA GUILLIERMONDII;

AGED; ANTIFUNGAL AGENTS; AUSTRALIA; CANDIDA; CANDIDIASIS; FEMALE; FUNGEMIA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES; POPULATION SURVEILLANCE; RISK FACTORS; SPECIES SPECIFICITY;

EID: 68249136893     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02821.x     Document Type: Article

References (36)

1. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3: 685-702.
2. Pappas PG. Invasive candidiasis. Infect Dis Clin North Am 2006; 20: 485-506.
3. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidaemia in adults and children hospitalised in the United States: A propensity analysis. Clin Infect Dis 2005; 41: 1232-1239.
4. Marchetti O, Bille J, Fluckiger U et al. Epidemiology of candidaemia in Swiss tertiary care hospitals: Secular trends, 1991-2000. Clin Infect Dis 2004; 38: 311-320.
5. Chen S, Slavin M, Nguyen Q et al. Active surveillance for candidaemia, Australia. Emerg Infect Dis 2006; 12: 1508-1516.
6. Hajjeh RA, Sofair AN, Harrison LH et al. Incidence of bloodstream infections due to Candida species and in.vitro susceptibities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004; 42: 1519-1527.
7. Kao AS, Brandt ME, Pruitt WR et al. The epidemiology of candidaemia in two United States cities: Results of a population-based active surveillance. Clin Infect Dis 1999; 29: 1164-1170.
8. Kremery V, Barnes AJ. Non- albicans Candida spp. causing fungemia: pathogencity and antifungal resistance. J Hosp Infect 2002; 50: 243-260.
9. Pfaller MA, Diekma DJ. Epidemiology of invasive candidiasis: A presistent public health problem. Clin Microbiol Rev 2007; 20: 133-163.
10. Pfaller M, Diekma DJ, Messer SA et al. In.vitro activities of voriconazole, posaconazole and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J Clin Microbiol 2003; 41: 78-83.
11. Girmenia C, Pizzarelli G, Cristini F et al. Candida guilliermondii fungemia in patients with haematologic malignancies. J Clin Microbiol 2006; 44: 2458-2462.
12. Atkinson BJ, Lewis RE, Kontoyiannis DP. Candida lusitaniae fungemia in cancer patietns: Risk factors for amphotericin.B failure and outcome. Med Mycol 2008; 46: 541-546.
13. Jabra-Rizk M, Johnson J, Forrest G, Mankes K, Meiller TF, Venezia RA. Prevalence of Candida dubliniensis at a large teaching hospital. Clin Infect Dis 2005; 41: 1064-1067.
14. Colombo AL, Melo ASA, Rosas RF et al. Outbreak of Candida rugosa candidaemia: An emerging pathogen that may be refractory to amphotericin.B therapy. Diagn Microbiol Infect Dis 2003; 46: 253-257.
15. Pfaller MA, Diekma DJ, Colombo AL et al. Candida rugosa, an emerging fungal pathogen with reistance to azoles: Geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program. J Clin Microbiol 2006; 44: 3578-3582.
16. Pfaller MA, Diekma DJ, Mendez M et al. Candida guilliermondi, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: Geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program. J Clin Microbiol 2006; 44: 3441-3556.
17. Sullivan DJ, Moran GP, Pinjon E et al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004; 4: 369-376.
18. Borg-von Zepelin M, Niederhaus T, Gross U, Seibold M, Monod M, Tintlenot K. Adherence of different Candida dubliniensis isolates in the presence of fluconazole. AIDS 2002; 16: 1237-1244.
19. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference Crit Care Med 2003; 31: 1250-1256.
20. Australian Government Department of Health and Aging. Infection control guidelines for the prevention of transmission of infectious diseases in the health care setting 2004. Available at: http://www.icg.health.gov.au (last accessed 11 November 2008).
21. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638.
22. Warren N, Hazen K. Candida, Cryptococcus and other yeasts of medical importance. In: Murray RP, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. Washington: American Society of Microbiology Press, 1999; 1184-1199.
23. Kurtzman CP, Fell JW. The yeasts, a taxonomic study, 4th edn. B.V. Amsterdam, The Netherlands: Elsevier Science, 1998.
24. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved standard, Vol, 22, 2nd edn. CLSI document M27-A2 protocol. Wayne, PA: CLSI, 2002, 15.
25. Meyer W, Latouche GN, Daniel HM et al. Identification of pathogenic yeasts of the imperfect genus Candida by polymerase chain reaction fingerprinting. Electrophoresis 1997; 18: 1548-1559.
26. Pfaller MA, Diekma DJ, Messer SA, Boyken L, Hollis RJ, Jones RN. In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Diagn Microbiol Infect Dis 2004; 48: 101-105.
27. Poikonen E, Lyytikainen O, Anttila V-J, Ruutu P. Candidaemia in Finland, 1995-1999. Emerg Infect Dis 2003; 9: 985-990.
28. Colombo AL, Nucci M, Park BJ et al. Epidemiology of candidaemia in Brazil: A nationwide sentinel surveillance of candidaemia in eleven medical centres. J Clin Microbiol 2006; 44: 2816-2823.
29. Colombo A, Guimaraes T, Silva LRBF et al. Prospective observational study of candidaemia in Sao Paulo, Brazil: Incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp Epidemiol 2007; 28: 570-576.
30. Sofair AN, Lyon GM, Huie-White S et al. Epidemiology of community-onset candidaemia in Connecticut and Maryland. Clin Infect Dis 2006; 43: 32-39.
31. Chow JK, Golan Y, Ruthazer R et al. Factors associated with candidaemia caused by non- albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 2008; 46: 1206-1213.
32. Playford EG, Marriott D, Nguyen Q et al. Candidaemia in non-neutropenic critically-ill patients: Risk factors for non- albicans Candida spp. Crit Care Med 2008; 36: 2034-2039.
33. Bodey GP, Mardini M, Hanna HA et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med 2002; 112: 380-385.
34. Jabra-Rizk MA, Falkler WA Jr, Merz WG, Baqui AAMA, Kelley JI, Meiller TF. Retrospective identification of Candida dublinienesis among Candida albicans clinical isolates from HIV and non-HIV individuals. J Clin Microbiol 2000; 38: 2423-2426.
35. Kremery V, Grausova S, Mraz M, Pichova E, Jurga L. Candida guilliermondii fungemia in cancer patients: Report of three cases. J Infect 1999; 5: 58-59.
36. Van Hal SJ, Stark D, Harkness J, Marriott D. Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia. Emerg Infect Dis 2008; 14: 327-329.